NIH: Chemo plus hormone therapy ups prostate cancer survival
Friday, December 6, 2013 - 10:30
in Health & Medicine
Men with hormone-sensitive metastatic prostate cancer who received the chemotherapy drug docetaxel given at the start of standard hormone therapy lived longer than patients who received hormone...